Champions Oncology (CSBR) Goodwill & Intangibles (2011 - 2026)
Champions Oncology (CSBR) recorded quarterly Goodwill & Intangibles of $335000.0 in Q1 2026, little changed quarter-over-quarter from $335000.0 in Q4 2025, and little changed on a YoY basis from $335000.0 in Q1 2025.
Champions Oncology (CSBR) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Champions Oncology's Goodwill & Intangibles history runs 16 years deep, the most recent figure standing at $335000.0 for Q1 2026.
- In Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $335000.0; the TTM figure through Jan 2026 stood at $335000.0 (changed 0.0% YoY), while the FY2025 annual figure was $335000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles was $335000.0 for Q1 2026 at Champions Oncology, roughly flat from $335000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $2.2 million in Q1 2022 to a low of $335000.0 in Q2 2022.
- Historically, Goodwill & Intangibles has averaged $446764.7 across 5 years, with a median of $335000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles soared 567.16% in 2022, then plunged 85.01% in 2023.
- A 5-year view of Goodwill & Intangibles shows it stood at $335000.0 in 2022, then changed by 0.0% to $335000.0 in 2023, then changed by 0.0% to $335000.0 in 2024, then changed by 0.0% to $335000.0 in 2025, then changed by 0.0% to $335000.0 in 2026.
- The last three Goodwill & Intangibles figures came in at $335000.0 (Q1 2026), $335000.0 (Q4 2025), and $335000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 335,000.00 |
| Oct 31, 2025 | 335,000.00 |
| Jul 31, 2025 | 335,000.00 |
| Apr 30, 2025 | 335,000.00 |
| Jan 31, 2025 | 335,000.00 |
| Oct 31, 2024 | 335,000.00 |
| Jul 31, 2024 | 335,000.00 |
| Apr 30, 2024 | 335,000.00 |
| Jan 31, 2024 | 335,000.00 |
| Oct 31, 2023 | 335,000.00 |
| Jul 31, 2023 | 335,000.00 |
| Apr 30, 2023 | 335,000.00 |
| Jan 31, 2023 | 335,000.00 |
| Oct 31, 2022 | 335,000.00 |
| Jul 31, 2022 | 335,000.00 |
| Apr 30, 2022 | 335,000.00 |
| Jan 31, 2022 | 2.24 Mn |
| Oct 31, 2021 | 335,000.00 |
| Jul 31, 2021 | 335,000.00 |
| Apr 30, 2021 | 335,000.00 |